Literature DB >> 25723361

Synthesis and properties of 2'-deoxy-2',4'-difluoroarabinose-modified nucleic acids.

Saúl Martínez-Montero1, Glen F Deleavey1, Arden Dierker-Viik1, Petra Lindovska1, Tatiana Ilina2, Guillem Portella3, Modesto Orozco3, Michael A Parniak2, Carlos González4, Masad J Damha1.   

Abstract

We report the synthesis, thermal stability, and RNase H substrate activity of 2'-deoxy-2',4'-difluoroarabino-modified nucleic acids. 2'-Deoxy-2',4'-difluoroarabinouridine (2,'4'-diF-araU) was prepared in a stereoselective way in six steps from 2'-deoxy-2'-fluoroarabinouridine (2'-F-araU). NMR analysis and quantum mechanical calculations at the nucleoside level reveal that introduction of 4'-fluorine introduces a strong bias toward the North conformation, despite the presence of the 2'-βF, which generally steers the sugar pucker toward the South/East conformation. Incorporation of the novel monomer into DNA results on a neutral to slightly stabilizing thermal effect on DNA-RNA hybrids. Insertion of 2',4'-diF-araU nucleotides in the DNA strand of a DNA-RNA hybrid decreases the rate of both human and HIV reverse transcriptase-associated RNase H-mediated cleavage of the complement RNA strand compared to that for an all-DNA strand or a DNA strand containing the corresponding 2'-F-araU nucleotide units, consistent with the notion that a 4'-fluorine in 2'-F-araU switches the preferred sugar conformation from DNA-like (South/East) to RNA-like (North).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25723361      PMCID: PMC4484724          DOI: 10.1021/jo502948t

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  22 in total

1.  Oligonucleotides comprised of alternating 2'-deoxy-2'-fluoro-beta-D-arabinonucleosides and D-2'-deoxyribonucleosides (2'F-ANA/DNA 'altimers') induce efficient RNA cleavage mediated by RNase H.

Authors:  Kyung-Lyum Min; Ekaterina Viazovkina; Annie Galarneau; Michael A Parniak; Masad J Damha
Journal:  Bioorg Med Chem Lett       Date:  2002-09-16       Impact factor: 2.823

Review 2.  RNA-based therapeutics: current progress and future prospects.

Authors:  John C Burnett; John J Rossi
Journal:  Chem Biol       Date:  2012-01-27

3.  Energetically important C-H···F-C pseudohydrogen bonding in water: evidence and application to rational design of oligonucleotides with high binding affinity.

Authors:  Maryam Yahyaee Anzahaee; Jonathan K Watts; Nageswara R Alla; Allen W Nicholson; Masad J Damha
Journal:  J Am Chem Soc       Date:  2010-12-20       Impact factor: 15.419

4.  Synthesis and antisense properties of fluoro cyclohexenyl nucleic acid (F-CeNA), a nuclease stable mimic of 2'-fluoro RNA.

Authors:  Punit P Seth; Jinghua Yu; Ali Jazayeri; Pradeep S Pallan; Charles R Allerson; Michael E Østergaard; Fengwu Liu; Piet Herdewijn; Martin Egli; Eric E Swayze
Journal:  J Org Chem       Date:  2012-05-18       Impact factor: 4.354

5.  Backbone FC-H···O hydrogen bonds in 2'F-substituted nucleic acids.

Authors:  Nerea Martin-Pintado; Glen F Deleavey; Guillem Portella; Ramón Campos-Olivas; Modesto Orozco; Masad J Damha; Carlos González
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-23       Impact factor: 15.336

6.  Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor.

Authors:  Qingguo Gong; Lakshmi Menon; Tatiana Ilina; Lena G Miller; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2010-11-29       Impact factor: 2.817

Review 7.  Designing chemically modified oligonucleotides for targeted gene silencing.

Authors:  Glen F Deleavey; Masad J Damha
Journal:  Chem Biol       Date:  2012-08-24

8.  Rigid 2',4'-difluororibonucleosides: synthesis, conformational analysis, and incorporation into nascent RNA by HCV polymerase.

Authors:  Saúl Martínez-Montero; Glen F Deleavey; Anupriya Kulkarni; Nerea Martín-Pintado; Petra Lindovska; Michael Thomson; Carlos González; Matthias Götte; Masad J Damha
Journal:  J Org Chem       Date:  2014-06-06       Impact factor: 4.354

9.  DRR regulates AKT activation to drive brain cancer invasion.

Authors:  A Dudley; M Sater; P U Le; G Trinh; M S Sadr; J Bergeron; G F Deleavey; B Bedell; M J Damha; K Petrecca
Journal:  Oncogene       Date:  2013-10-21       Impact factor: 9.867

10.  Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy.

Authors:  Mary P McGowan; Jean-Claude Tardif; Richard Ceska; Lesley J Burgess; Handrean Soran; Ioanna Gouni-Berthold; Gilbert Wagener; Scott Chasan-Taber
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

View more
  4 in total

1.  Synthesis and Conformational Analysis of Fluorinated Uridine Analogues Provide Insight into a Neighbouring-Group Participation Mechanism.

Authors:  Freideriki Michailidou; Tomas Lebl; Alexandra M Z Slawin; Sunil Vishnuprasadji Sharma; Murray J B Brown; Rebecca Jane Miriam Goss
Journal:  Molecules       Date:  2020-11-25       Impact factor: 4.411

2.  Influence of 4'-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-2.

Authors:  Zihua Zheng; Elisabetta Groaz; Robert Snoeck; Steven De Jonghe; Piet Herdewijn; Graciela Andrei
Journal:  ACS Med Chem Lett       Date:  2020-12-09       Impact factor: 4.345

3.  Structural basis for the synergy of 4'- and 2'-modifications on siRNA nuclease resistance, thermal stability and RNAi activity.

Authors:  Joel M Harp; Dale C Guenther; Anna Bisbe; Lydia Perkins; Shigeo Matsuda; Gopal R Bommineni; Ivan Zlatev; Donald J Foster; Nate Taneja; Klaus Charisse; Martin A Maier; Kallanthottathil G Rajeev; Muthiah Manoharan; Martin Egli
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

4.  Synthesis and Antisense Properties of 2'β-F-Arabinouridine Modified Oligonucleotides with 4'-C-OMe Substituent.

Authors:  Xiao-Yang He; Jing Wang; Dan-Dan Lu; Sheng-Qi Wang
Journal:  Molecules       Date:  2018-09-17       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.